Today

Agents

Chat

Arena

Discover

More

App

BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule - BBIO News | Rallies

BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule

BBIO•2026-08-11

Inducement grants reported under Nasdaq rule

Aug. 11 (Reuters) - BridgeBio Pharma, Inc. BBIO.O:

BridgeBio Pharma reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Source text: ID:nGNX3PXsFW

Further company coverage: BBIO.O

Related News

Openlane Announces Secondary Offering Of Common Stock, Including Concurrent Share Repurchase

OPLN•2026-08-11

Westlake Executive Chairman Albert Chao melepas saham senilai $3,12 juta

WLK•2026-08-11

Illinois Tool Works Prices $1.50 Billion Senior Notes Due 2029 At 4.650% Coupon

ITW

•

2026-08-11

MacroGenics rises on $10 million milestone payment from Gilead

MGNX•2026-08-11

Chairman & CEO David Golub lepas 1.676.387 saham Golub Capital BDC senilai $21,89 juta

GBDC•2026-08-11